MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

Lantheus Holdings Inc

Chiusa

SettoreSettore sanitario

53.49 3

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

49.47

Massimo

53.55

Metriche Chiave

By Trading Economics

Entrata

5.8M

79M

Vendite

5.3M

378M

P/E

Media del settore

14.016

37.257

Margine di Profitto

20.832

Dipendenti

808

EBITDA

7.7M

123M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+55.29% upside

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-1.4B

3.6B

Apertura precedente

50.49

Chiusura precedente

53.49

Punteggio Tecnico

By Trading Central

Fiducia

Very Strong Bearish Evidence

Lantheus Holdings Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

8 ott 2025, 20:45 UTC

Utili

Costco Wholesale Sales Climb in September, Early October

8 ott 2025, 20:12 UTC

I principali Market Mover
Acquisizioni, Fusioni, Takeovers

TaskUs Shares Fall After Holders Reject Take-Private Deal

8 ott 2025, 16:39 UTC

I principali Market Mover

Mining Shares Rise as Gold Prices Soar

8 ott 2025, 23:45 UTC

Discorsi di Mercato

Nikkei May Rise on Weaker Yen -- Market Talk

8 ott 2025, 23:43 UTC

Discorsi di Mercato

Gold Falls on Possible Profit-Taking -- Market Talk

8 ott 2025, 23:18 UTC

Acquisizioni, Fusioni, Takeovers

JD Logistics to Finance Acquisition Using Internal Funds

8 ott 2025, 23:17 UTC

Acquisizioni, Fusioni, Takeovers

JD Logistics to Buy On-Demand Delivery Services Business for US$270.0M

8 ott 2025, 23:16 UTC

Acquisizioni, Fusioni, Takeovers

JD Logistics to Buy JD.com's On-Demand Delivery Services Business Dajiang and Dasheng

8 ott 2025, 21:54 UTC

Discorsi di Mercato
Utili

James Hardie Could Beat Annual Earnings Goal -- Market Talk

8 ott 2025, 21:30 UTC

Discorsi di Mercato

Boab Metals Bull Delivers Second Upgrade in a Month -- Market Talk

8 ott 2025, 21:26 UTC

Discorsi di Mercato
Utili

Transurban's 1Q Traffic Growth Beats Hopes -- Market Talk

8 ott 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

8 ott 2025, 19:15 UTC

Discorsi di Mercato

Geopolitical Risk Supports Gains in Oil Futures -- Market Talk

8 ott 2025, 19:01 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Pull Back Ahead of Storage Data -- Market Talk

8 ott 2025, 18:47 UTC

Discorsi di Mercato

Coca-Cola North America Sales Buoy International Weakness -- Market Talk

8 ott 2025, 18:46 UTC

Acquisizioni, Fusioni, Takeovers

TaskUs: Neither Party Will Be Required to Pay Termination Fee as Result of Planned Mutual Decision to Terminate

8 ott 2025, 18:46 UTC

Acquisizioni, Fusioni, Takeovers

TaskUs Will Remain a Publicly Traded Co >TASK

8 ott 2025, 18:46 UTC

Acquisizioni, Fusioni, Takeovers

TaskUs Does Not Plan to Convene Another Special Meeting of Stockholders >TASK

8 ott 2025, 18:45 UTC

Acquisizioni, Fusioni, Takeovers

TaskUs Didn't Receive Votes Necessary to Approve Transaction Agreement With Affil of Blackstone >TASK

8 ott 2025, 18:07 UTC

Discorsi di Mercato

Mexico's Inflation Seen Edging Up in September -- Market Talk

8 ott 2025, 16:20 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Energy & Utilities Roundup: Market Talk

8 ott 2025, 16:20 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

8 ott 2025, 16:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

8 ott 2025, 15:57 UTC

Discorsi di Mercato

Oil Rises Despite U.S. Crude Stockpiles Build -- Market Talk

8 ott 2025, 15:56 UTC

Discorsi di Mercato

Teck Resources' Chile Mine Issues Appear Transitory -- Market Talk

8 ott 2025, 15:53 UTC

Discorsi di Mercato

Argentine Sovereign Debt Seen as Attractive -- Market Talk

8 ott 2025, 15:44 UTC

Acquisizioni, Fusioni, Takeovers

Staar Surgical: Broadwood's Proposal to Vote Down Merger Could Allow It to Take Control Without Paying Any Premium

8 ott 2025, 15:44 UTC

Acquisizioni, Fusioni, Takeovers

Staar Surgical Board and Management Disagree With Recommendation Issued by Glass Lewis >STAA

8 ott 2025, 15:43 UTC

Acquisizioni, Fusioni, Takeovers

STAAR Surgical Board Reiterates Unanimous Recommendation Holders Vote for Alcon Merger

8 ott 2025, 15:42 UTC

Acquisizioni, Fusioni, Takeovers

Oracle Is a Buy-the-Dip Opportunity, Analyst Says. How the Stock Could Rise 23%. -- Barrons.com

Confronto tra pari

Modifica del prezzo

Lantheus Holdings Inc Previsione

Obiettivo di Prezzo

By TipRanks

55.29% in crescita

Previsioni per 12 mesi

Media 80.5 USD  55.29%

Alto 110 USD

Basso 58 USD

Basato su 10 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Lantheus Holdings Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

10 ratings

7

Acquista

3

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

79.24 / 103.64Supporto e resistenza

A breve termine

Very Strong Bearish Evidence

A termine intermedio

Weak Bullish Evidence

A lungo termine

Neutral Evidence

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Lantheus Holdings Inc

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. The company also offers Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; and PYLARIFY AI, an AI-based medical device software to perform quantitative assessment of PSMA PET/CT images in prostate cancer. In addition, it develops 1095, a PSMA-targeted iodine-131-labeled small molecule; PNT2002, a radiopharmaceutical therapy to treat mCRPC; PNT2003, an SSTR therapy that treats patients with SSTR-positive neuroendocrine tumors; MK-6240, a F 18-labeled PET imaging agent that targets Tau tangles in Alzheimer's disease; LNTH-1363S, an fibroblast activation protein, alpha targeted, copper-64 labeled PET imaging agent; and flurpiridaz used to assess blood flow to the heart;. It has collaboration agreements with GE Healthcare; NanoMab Technology Limited; Curium; RefleXion Medical, Inc.; POINT; Regeneron Pharmaceuticals, Inc; and Ratio Therapeutics LLC. The company was founded in 1956 and is based in Bedford, Massachusetts.
help-icon Live chat